Titulo:
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo
.
Guardado en:
1794-2470
2462-9448
18
2020-09-25
67
74
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_unicolmayor_nova_9_article_1815 |
|---|---|
| record_format |
ojs |
| spelling |
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo Hernández Rojas, Edith del Carmen Almonacid Urrego, Isabel Cristina Rocha Chamorro, Andrea Catalina Salcedo Pretelt, Irlena 18 35 Núm. 35 , Año 2020 : Especial Covid-19 Artículo de revista Journal article 2020-09-25 16:13:55 2020-09-25 16:13:55 2020-09-25 application/pdf Universidad Colegio Mayor de Cundinamarca y Universidad Nacional Abierta y a Distancia - UNAD NOVA 1794-2470 2462-9448 https://revistas.unicolmayor.edu.co/index.php/nova/article/view/1815 10.22490/24629448.4188 https://doi.org/10.22490/24629448.4188 https://creativecommons.org/licenses/by-nc-sa/4.0/ 67 74 GenBank. Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. [Internet]. [Consultado el 11 feb 2020]. Disponible en: http://www.ncbi.nlm.nih.gov/nuccore/MN908947.3. World Health Organization (WHO). DRAFT landscape of COVID-19 candidate vaccines-20 April 2020. [Internet]. Disponible en: https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1. Lawrence C, Mascola J, Fauci A, Collins F. A strategic approach to COVID-19 vaccine R&D. Science [Internet]. 2020. [Consultado 29 de may 2020]; 368 ISSUE 6494. Disponible en: DOI: 10.1126/science.abc5312 Ewen C. The race for coronavirus vaccines: a graphical guide. Nature [Internet]. 2020 [Consultado Apr 2020]; 580(7805):576-577. Disponible en: DOI: 10.1038/d41586-020-01221-y. Inovio. Inovio accelerates timeline for COVID-19 DNA vaccine INO-4800 [pressmeddelande]. 3 mar 2020 [citerat 19 mar 2020]. htt p: https://www.prnewswire.com/news-releases/inovio-accelerates-timeline-for-covid-19-dna-vaccine-ino-4800-301015031.html. ClinicalTrials.gov. Safety and immunogenicity study of 2019-nCoV vaccine (mRNA-1273) to prevent SARS-CoV-2 infection [Internet]. [Consultado 29 Mar 2020]. NCT04283461. Disponible en: https://clinicaltrials.gov/ct2/show/NCT04283461. Susannah L. At least 68 vaccine candidates under development. Lakartidningen [Internet] 2020 [Consultado 6 Apr 2020];117:F3MZ. Lamirande EW, DeDiego ML, Roberts A, Jackson JP, Alvarez E, Sheahan T, et al. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters. J. Virol. 2008;82(15):7721–7724. Lin JT, Zhang JS, Su N, et al. Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine. Antivir Ther. 2007;12(7):1107-13. Codagenix, Inc. Codagenix and Serum Institute of India initiate co-development of a scalable, live-attenuated vaccine against the 2019 novel coronavirus, COVID-19 [Internet]. [Consultado 19 Mar 2020]. Disponible en: https://www.prnewswire.com/news-releases/codagenix-and-serum-institute-of-india-initiate-co-development-of-a-scalable-live-attenuated-vaccine-against-the-2019-novel-coronavirus-covid-19-301004654.html. ClinicalTrials.gov. Safety and immunogenicity of a candidate MERS-CoV vaccine (MERS001) [Internet]. [Consultado 20 mar 2020]. NCT03399578. Disponible en: https://clinicaltrials.gov/ct2/show/NCT03399578. Chinese Clinical Trial Register (ChiCTR). A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector). [Internet]. [Consultado 29 Mar 2020]. ChiCTR2000030906. Disponible en: http://www.chictr.org.cn/showprojen.aspx?proj=51154. Chappell K, Watterson D, Young P. Rapid response pipeline for stabilized subunit vaccines. Vaccine Technology VII [Internet]. 2018 [consultado 20 Jun 2018]. Disponible en: https://dc.engconfintl.org/vt_vii/111. Clover Biopharmaceuticals. Comunicado de prensa: Clover successfully produced 2019-nCoV subunit vaccine candidate and detected cross-reacting antibodies from sera of multiple infected patients [Internet]. 2020. [Consultado 19 Mar 2020]. Disponible en: http://www.cloverbiopharma.com/index.php?m=content&c=index&a=show&catid=11&id=41. Novavax. Comunicado de prensa: Novavax advances development of novel COVID-19 vaccine [Internet]. 2020. [Consultado 19 Mar 2020]. Disponible en: http://ir.novavax.com/news-releases/news-release-details/novavax-advances-development-novel-covid-19-vaccine. Tung TL, Zacharias A, Arun K, Gómez R, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020:19(5)305-306. Cormac S. Questions remain following first COVID-19 vaccine results. Nat Biotechnol [Internet] 2020. DOI: 10.1038/D41587-020-00015. https://revistas.unicolmayor.edu.co/index.php/nova/article/download/1815/2688 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/redcol/resource_type/ARTREF info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |
| institution |
UNIVERSIDAD COLEGIO MAYOR DE CUNDINAMARCA |
| thumbnail |
https://nuevo.metarevistas.org/UNIVERSIDADCOLEGIOMAYORDECUNDINAMARCA/logo.png |
| country_str |
Colombia |
| collection |
NOVA |
| title |
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo |
| spellingShingle |
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo Hernández Rojas, Edith del Carmen Almonacid Urrego, Isabel Cristina Rocha Chamorro, Andrea Catalina Salcedo Pretelt, Irlena |
| title_short |
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo |
| title_full |
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo |
| title_fullStr |
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo |
| title_full_unstemmed |
Vacunas para COVID-19: Estado actual y perspectivas para su desarrollo |
| title_sort |
vacunas para covid-19: estado actual y perspectivas para su desarrollo |
| author |
Hernández Rojas, Edith del Carmen Almonacid Urrego, Isabel Cristina Rocha Chamorro, Andrea Catalina Salcedo Pretelt, Irlena |
| author_facet |
Hernández Rojas, Edith del Carmen Almonacid Urrego, Isabel Cristina Rocha Chamorro, Andrea Catalina Salcedo Pretelt, Irlena |
| citationvolume |
18 |
| citationissue |
35 |
| citationedition |
Núm. 35 , Año 2020 : Especial Covid-19 |
| publisher |
Universidad Colegio Mayor de Cundinamarca y Universidad Nacional Abierta y a Distancia - UNAD |
| ispartofjournal |
NOVA |
| source |
https://revistas.unicolmayor.edu.co/index.php/nova/article/view/1815 |
| language |
|
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0/ info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2020-09-25 |
| date_accessioned |
2020-09-25 16:13:55 |
| date_available |
2020-09-25 16:13:55 |
| url |
https://revistas.unicolmayor.edu.co/index.php/nova/article/view/1815 |
| url_doi |
https://doi.org/10.22490/24629448.4188 |
| issn |
1794-2470 |
| eissn |
2462-9448 |
| doi |
10.22490/24629448.4188 |
| citationstartpage |
67 |
| citationendpage |
74 |
| url2_str_mv |
https://revistas.unicolmayor.edu.co/index.php/nova/article/download/1815/2688 |
| _version_ |
1811200269832159232 |